Campbell Soup Company primarily operates in the food and kindred products industry.
It is an iconic American staple with a portfolio of trusted, pantry-stable brands that provide consistent consumer demand.
Updated: February 15, 2026, 16:00 EST
Based on the provided analysis, Campbell Soup Company (CPB) presents a mixed but cautiously optimistic picture for investors.
Technical Analysis CPB shows encouraging signs of a rebound with a 10% monthly gain, indicating potential bullish momentum. However, the stock remains deep in oversold territory, trading much closer to its 52-week low than its high, suggesting that while the worst may be over, a full recovery is not yet assured.
Fundamentals & Valuation The company's fundamentals are solid, with strong revenue growth and improved profit margins, highlighting effective operations. CPB appears reasonably valued, with a forward P/E and a PEG ratio below 1.0 suggesting the stock is inexpensive relative to its expected earnings growth, which is attractive for a stable consumer staples company.
Risk Assessment A key positive is CPB's low correlation to the broader market (negative Beta), offering potential diversification benefits. While the significant past drawdown highlights volatility, the lack of speculative short interest suggests the market does not perceive substantial immediate downside risk.
Recommendation CPB is worth considering for a BUY, particularly for value-oriented investors seeking a stable, defensive stock. The combination of positive recent momentum, solid fundamentals, and attractive valuation metrics presents a compelling case. The stock's oversold condition and low market correlation add to its appeal for a portfolio seeking diversification and potential rebound candidates. (Note: This is not investment advice, for reference only.)
Based on the analysis, the 12-month outlook for Campbell Soup (CPB) is guarded but leans positive, driven by its defensive characteristics and valuation appeal. The key catalyst will be the company's ability to sustain its operational momentum, translating solid revenue growth and improved margins into consistent earnings that justify a higher valuation. A potential technical rebound from deeply oversold levels could provide additional upward pressure.
The primary risk is that the stock remains out of favor, failing to attract sufficient buyer interest to overcome the residual negative sentiment from its significant past drawdown, which could keep it range-bound near current levels. While a specific analyst target is unavailable, a reasonable 12-month price target range could be $32-$36, reflecting a moderate re-rating based on its attractive PEG ratio and defensive profile, contingent on stable market conditions.
Most Wall Street analysts are optimistic about Campbell Soup Company's 12-month outlook, with consensus target around $29.49, indicating expected upside potential.
Overall, CPB has investment potential but also faces challenges. Here are key factors to weigh before investing.
CPB has demonstrated notable volatility but recently showed positive momentum despite remaining well below previous highs.
Short-term performance reveals a strong 10.0% monthly rebound, though the stock remains down 3.75% over three months and has underperformed the broader market by 3.8% in that period. The negative beta indicates the stock has moved counter to market trends during this timeframe.
At $29.49, CPB trades closer to its 52-week low ($25.62) than high ($43.85), suggesting the stock remains in oversold territory despite the recent rally. The substantial 37.96% maximum drawdown further supports this oversold condition relative to the past year's trading range.
| Period | CPB Return | S&P 500 |
|---|---|---|
| 1m | +10.0% | -1.2% |
| 3m | -3.8% | +0.1% |
| 6m | -10.4% | +7.8% |
| 1y | -22.7% | +11.5% |
| ytd | +6.4% | -0.2% |
Revenue & Profitability: CPB posted strong revenue growth, with Q1 2026 revenue increasing to $2.68 billion from $2.32 billion in the prior quarter. Profitability was solid, with a net profit margin of 7.2% in Q1, which improved from 6.2% in the previous quarter, indicating an effective control over costs despite a slight contraction in the gross profit margin.
Financial Health: The company's financial leverage is moderate, as indicated by a debt-to-equity ratio of 1.76. The interest coverage ratio of 4.16 suggests the company earns sufficient operating income to cover its interest obligations. However, the cash ratio is low at 0.05, signaling limited immediate liquidity from cash and equivalents alone.
Operational Efficiency: CPB's return on equity (ROE) was 4.9% in Q1, reflecting modest efficiency in generating profits from shareholder equity. The asset turnover ratio of 0.18 suggests the company could improve its efficiency in utilizing assets to generate sales. The cash conversion cycle of approximately 28 days indicates effective management of working capital.
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Try Now & Get Tesla Stock RewardBased on the available metrics, CPB appears reasonably valued to slightly undervalued. The forward P/E ratio of 11.5 is significantly lower than the trailing P/E of 14.6, indicating expected earnings growth. The PEG ratio well below 1.0 strongly suggests the stock is inexpensive relative to its growth prospects, though the high EV/EBITDA warrants caution regarding its capital structure or one-time factors.
Without specific industry average data for a peer comparison, a definitive relative valuation is not possible. However, the low PEG ratio and a forward P/E in the low teens often compare favorably for a stable consumer staples company like Campbell Soup. For a more precise analysis, a comparison against the average P/E, PEG, and EV/EBITDA of its direct competitors would be required.
Based on the provided metrics, CPB exhibits minimal volatility risk relative to the broader market, as indicated by its near-zero negative Beta of -0.036. However, the stock has demonstrated significant price vulnerability over the past year, evidenced by a substantial maximum drawdown of -37.96%, suggesting investors have experienced considerable peak-to-trough losses despite its low market correlation.
CPB faces limited perceived downside pressure from speculative short-selling, as indicated by the negligible reported short interest. Nonetheless, an absence of short interest does not eliminate other fundamental or sector-specific risks, and investors should assess factors such as company-specific operational challenges or industry-wide headwinds that contributed to the steep drawdown.
Neutral. The stock shows value potential with a low PEG ratio and recent oversold technical conditions, but analyst pessimism and fundamental pressures on revenue/earnings create significant headwinds. This stock may suit patient, contrarian investors willing to bet on a turnaround, but it carries a non-trivial risk of being a value trap given broader negative sentiment and operational challenges.
Based on the provided data, CPB stock appears to be undervalued. Key valuation metrics support this view: its forward P/E of 11.5 is reasonable, but a PEG ratio of 0.35 (significantly below 1.0) strongly indicates the stock is inexpensive relative to its earnings growth projections. Furthermore, a Price-to-Sales ratio of 0.86 is attractive. The undervaluation is primarily driven by strong growth expectations, as evidenced by the lower forward P/E and solid recent revenue and profit margin improvements, which are not yet fully reflected in the price.
Based on the provided information, here are the key risks of holding CPB stock, ordered by importance:
1. Significant Price Vulnerability: Despite low market correlation, the stock has experienced a severe 37.96% maximum drawdown, indicating high susceptibility to factors that have caused substantial investor losses. 2. Industry and Operational Headwinds: The steep price decline suggests the company faces significant challenges, such as shifting consumer preferences or intense competitive pressure in the packaged food industry, which are not reflected in its negative beta. 3. Limited Short-Term Liquidity: The cash ratio of 0.05 indicates a very low level of cash to cover immediate liabilities, which could constrain operational flexibility or amplify distress if faced with an unexpected expense or downturn. 4. Inefficient Asset Utilization: An asset turnover ratio of 0.18 points to potential operational inefficiency, requiring a large asset base to generate sales, which could hinder profitability and returns, especially in a low-margin industry.
Based on the provided analysis, my forecast for Campbell Soup (CPB) stock through 2026 is as follows:
My base case target for 2026 is in the $34-$38 range, with a bull case of up to $42, driven by defensive demand, improving profitability, and operational efficiency gains. The primary assumptions are that the company sustains its recent revenue growth and margin improvement trajectory while stable market conditions favor its non-cyclical profile. This forecast is contingent on CPB successfully overcoming negative sentiment and attracting investor interest for a valuation re-rating, introducing significant uncertainty given the stock's recent challenges. The low cash ratio and modest asset turnover remain key areas to monitor for risks to this outlook.